Literature DB >> 22883290

Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications.

Jonathan B Ford1, Timothy E Albertson, Kelly P Owen, Mark E Sutter, W Blake McKinney.   

Abstract

Amphetamine-derived medications are being prescribed with increasing frequency to younger pediatric patients to treat attention deficit hyperactivity disorder. Although choreiform movements were reported in adults with amphetamine abuse and in those under therapeutic treatment for attention deficit hyperactivity disorder, previous literature concerning the pediatric population is spare. We describe two children who developed chorea after ingesting amphetamine-derived medications prescribed to treat attention deficit hyperactivity disorder. Patient 1, a 10-year-old boy, accidently received an extra dose of lisdexamfetamine dimesylate the night before the onset of acute chorea involving his arms, legs, and trunk. Patient 2, an 8-month-old boy, accidentally ingested his stepbrother's mixed amphetamine salts (Adderall XR) and developed acute chorea. Benzodiazepines, diphenhydramine, benztropine, and opioids did not suppress the chorea in either case. The 10-year-old received haloperidol, which significantly improved his abnormal findings, and he returned to baseline in approximately 48 hours. The 8-month-old was observed in the pediatric intensive care unit, and his signs resolved by 72 hours. Our cases demonstrate that choreiform movements of sustained duration can occur in children with acute supratherapeutic ingestions of amphetamine-derived medications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22883290     DOI: 10.1016/j.pediatrneurol.2012.05.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

1.  An Infant with a Prolonged Sympathomimetic Toxidrome after Lisdexamfetamine Dimesylate Ingestion.

Authors:  Kelly E Wood; Matthew D Krasowski
Journal:  J Med Toxicol       Date:  2016-06-08

Review 2.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

3.  Worsening Choreoathetosis in Huntington's Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report.

Authors:  Clayton J Hamilton; Tysen K Timmer; Robert C Munjal; Fernando Cardozo-Pelaez; Ian R Mcgrane
Journal:  Innov Clin Neurosci       Date:  2018-08-01

Review 4.  Psychostimulants and movement disorders.

Authors:  Andres Asser; Pille Taba
Journal:  Front Neurol       Date:  2015-04-20       Impact factor: 4.003

Review 5.  A systematic review of the safety of lisdexamfetamine dimesylate.

Authors:  David R Coghill; Beatriz Caballero; Shaw Sorooshian; Richard Civil
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

6.  Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine.

Authors:  Ozalp Ekinci; Cemre Yaşöz; Selin Ayşe İpek Baş; Nazan Ekinci; Özge İpek Doğan
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

7.  A case series involving young children presenting with accidental ingestion of amphetamine based stimulants.

Authors:  Kelly E Wood; Patrick J McCarthy; Matthew D Krasowski
Journal:  Toxicol Rep       Date:  2018-11-03

Review 8.  Treatment of Secondary Chorea: A Review of the Current Literature.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.